Literature DB >> 6103521

Estrogens in tardive dyskinesia in male psychiatric patients.

A Villeneuve, T Cazejust, M Côté.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103521     DOI: 10.1159/000117746

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


× No keyword cloud information.
  7 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Psychotropic properties of ovarian estrogens (review).

Authors:  E B Arushanyan; G K Borovkova
Journal:  Neurosci Behav Physiol       Date:  1989 Jan-Feb

3.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

Review 4.  Pharmacological options for the management of dyskinesias.

Authors:  H Shale; C Tanner
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

Review 5.  Schizophrenia and oestrogens--is there an association?

Authors:  A Riecher-Rössler; H Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments.

Authors:  H Häfner; S Behrens; J De Vry; W F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 7.  Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Authors:  Karla Soares-Weiser; John Rathbone; Yusuke Ogawa; Kiyomi Shinohara; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.